echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood: Prevention of recurrent thrombotic events in children with central venous catheter-related venous thrombosis

    Blood: Prevention of recurrent thrombotic events in children with central venous catheter-related venous thrombosis

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Central point: Children with a history of central venous catheter (CVC)-related thromboembolism are at increased risk of recurrence of venous thromboembolism; subsequent placement of central venous catheters using full-dose anticoagulation as secondary prevention is associated with a 65% reduction in thromboembolism .


    Central point: Children with a history of central venous catheter (CVC)-related thromboembolism are at increased risk of recurrence of venous thromboembolism; subsequent placement of central venous catheters using full-dose anticoagulation as secondary prevention is associated with a 65% reduction in thromboembolism .


    This is a single-center retrospective study to evaluate the efficacy of secondary prevention in children with a history of CVC-VTE, and to determine the efficacy of patients ≤19 years of age with a history of index CVC-VTE during 2003-2013 Risk factors associated with recurrent VTE


    Researchers collected relevant data including clinical and demographic factors, subsequent CVC placement, secondary prevention strategies, recurrent VTE and bleeding


    The correlation between the number of CVC and the incidence of non-thrombotic events

    The correlation between the number of CVC and the incidence of non-thrombotic events

    A total of 373 children with a history of index CVC-VTE were included, of which 239 (64.


    17.


    The correlation between the presence or absence of CVD and the incidence of thrombotic events

    The correlation between the presence or absence of CVD and the incidence of thrombotic events

    The use of full-dose anticoagulants as secondary preventive measures is associated with a reduction in the odds ratio of recurrent CVC-VTE (OR 0.


    The use of full-dose anticoagulant as a secondary preventive measure is related to the reduction in the odds ratio of recurrent CVC-VTE

    In summary, children with a history of CVC-VTE have an increased risk of recurrent VTE


    Children with a history of CVC-VTE have an increased risk of recurrent VTE


    Original source:

    Helen Havens Clark, Lance Ballester, Hilary B Whitworth, et al.


    Prevention of Recurrent Thrombotic Events in Children with Central Venous Catheter-Associated Venous Thrombosis

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.